Evenswiss was present last week at CCR London. CCR London connected the surgical and non-surgical medical aesthetics specialties and CCR has quickly become the UK’s leading educational event, delivering free CPD certified conferences covering both surgical and non-surgical procedures. With over 130 exhibitors, we were one together with our fabulous Evenswiss UK- team. Evenswiss and our unique patent Dermatopoietin took great steps towards deeper awareness and recognition in this field.
Evenswiss is so proud to be selected in CCR London as Innovation Trial 2022!
The Medical Aesthetic community and committee was inspired by the innovation and technology of Dermatopoietin.
We are very happy that our technology efforts and forward-thinking vision is on this stage and at such an important point.